12/10/2010 15:00:00

Alion Awarded EPA Contract Valued at up to $72 Million to Conduct Research on Human Pollutant Exposures

Alion Science and Technology, an employee-owned technology solutions

company, was awarded a five-year task-order from the Environmental

Protection Agency (EPA), worth a maximum of $72 million, to continue its

work providing research support to assess exposure to atmospheric

pollutants and other materials that have the potential to cause adverse

human health effects.

Alion supports EPA’s Office of Research and Development by assisting

with the conduct of research that characterizes human pollutant

exposures across a broad spectrum. Our subcontractor RTI International

is a key partner in this effort. Results will be applied to practical

efforts related to air quality measurement, pollution control and

homeland security.

“We support the continuing improvement in our understanding of how

people become exposed to air pollutants,” explained Chris Amos, Alion

Senior Vice President and Manager of the company’s Technology Solutions

Group. “Alion has a long history with EPA, dating back to 1973, in

conducting atmospheric sciences and environmental methods development

research, with an increased emphasis on studying human exposure.

Ultimately, the research we are conducting now may help prevent negative

health effects from pollutants.”

Under the contract, Alion will develop and support human exposure models

and support research in aerosol and human exposure studies. Pollutants

and other compounds will be sampled and analyzed in air, water, food,

dust, soil and biological media, and tracked through inhalation, dermal

exposure and ingestion.

Other subcontractors on the five-year contract include The McConnell

Group and Alpha-Gamma Technologies.

The mission of EPA is to protect human health and the environment. EPA's

purpose is to ensure that all Americans are protected from significant

risks to human health and the environment where they live, learn and

work.

About Alion Science and Technology

Alion Science and Technology is an employee-owned technology solutions

company delivering technical expertise and operational support to the

Department of Defense, civilian government agencies and commercial

customers. Building on almost 75 years of R&D and engineering expertise,

Alion brings innovation and insight to multiple business areas: naval

architecture & marine engineering; defense operations; modeling &

simulation; technology integration; information technology & wireless

communications; and energy and environmental sciences. Based in McLean,

Virginia, Alion employee-owners are located at major offices, customer

sites and laboratories worldwide. For more information, call

877.771.6252 or visit Alion online at www.alionscience.com.

This press release contains information about management’s view of

Alion’s future expectations, plans and prospects that constitute

forward-looking statements for purposes of the safe harbor provisions

under The Private Securities Litigation Reform Act of 1995. Actual

results may differ materially from those indicated by these

forward-looking statements as a result of a variety of risk factors and

uncertainties discussed in documents periodically filed by Alion with

the SEC.

Due to such uncertainties and risks, readers are

cautioned not to place undue reliance on such forward-looking

statements, which speak only as of the date hereof.

Alion Science and Technology

Peter J. Jacobs, 703-269-3473

pjacobs@alionscience.com

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
22 Jul
BAVA
Er der rigtigt forstået, at vi venter på at flere i forsøget skal dø før vi kan se på resultatet?   ..
51
21 Jul
FING-B
Du er overalt. Du skriver i Fingersprint trådene og opretter derefter ny tråd med samme indhold. Nu ..
45
23 Jul
BAVA
Spændende og meget relevante spørgsmål Pits.   Vi har indtil nu nået de første to analysetidspunkte..
25
19 Jul
GEN
Ja, det ligner simpelthen ingenting. Siden starten af 2012 er Genmab under ledelse af Jan W. kun ste..
24
25 Jul
FING-B
I dag hvor Finger er under et mindre pres er det vigtigt at man holder fast i sin strategi og spørg ..
20
23 Jul
BAVA
Gode spørgsmål!   Ja, der er en klar sammenhæng mellem tilvalg/fravalg af behandling indenfor prosta..
15
22 Jul
NOVO-B
Stærk analyse.  
14
20 Jul
 
Et kæmpe tab. En sindsyg dygtig, højt respekteret og solid klippe af "sund fornuft" som igennem mang..
11
08:06
PNDORA
Haha du sidder stadig der og skriger ovre i hjørnet.......mens vi andre har nydt ferien....Bliver du..
10
22 Jul
VWS
Bid mærke i, at nu er selv energikæmpen GE mere grøn end sort: http://www.business.dk/energi/groen-e..
10

Alliance Trust PLC : Transaction in Own Shares

26/07/2017 07:00:05
26 July 2017  Alliance Trust PLC TRANSACTION IN OWN SHARES  The Board of Alliance Trust PLC ("the Company") announces that on 25 July 2017 the Company purchased for cancellation 100,000 ordinary shares of 2.5p each at a price of 716.5p per share.  Therefore, the total number of voting rights in the Company is now 352,188,122.    The above figure (352,188,122) may be used by shareholders a..

Alliance Trust PLC : Net Asset Value(s)

25/07/2017 14:52:29
ALLIANCE TRUST PLC                                    At the close of business on Monday 24 July 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 757.0p -       including income, 765.7p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding income,..

Novae Group plc: Holdings in Company

25/07/2017 13:01:24
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
ATOS : First half 2017 results
2
WORLDLINE SA : First half 2017 results
3
Columbia University Medical Center’s Center for Biomedical Informatics Collaborates with Admera Health in a Clinical Study, Evaluating Pharmacogenetics in Psychiatric Medications
4
Outokumpu - Solid profitability despite ferrochrome production challenges, Group adjusted EBITDA at EUR 199 million
5
STMicroelectronics Reports 2017 Second Quarter and First Half Financial Results

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 July 2017 09:50:02
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170720.2 - EUROWEB4 - 2017-07-26 10:50:02 - 2017-07-26 09:50:02 - 1000 - Website: OKAY